This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Features and management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Clinical features:

  • epigastric discomfort and nausea

Endoscopic features:

  • may be no abnormality visible at gastroscopy; in general, erythema and erosions in the antral mucosa. If there is associated duodenitis then this increases the likelihood of H. pylori.

Diagnosis:

  • listed separately

Management:

  • NICE guidance states that H. pylori-positive peptic ulcer disease or non-ulcer dyspepsia requires treatment with H. pylori eradication therapy. For more detailed regarding the NICE guideline see linked item

Prognosis:

  • natural history is uncertain. Often progresses to patchy atrophy (does not usually lead to complete achlorhydria). There is thought to be a 3-4 fold increased risk of gastric carcinoma. There is evidence linking this form of gastritis with the development of lymphoma of mucosa-associated lymphoid tissue type

Reference:

  1. NICE (September 2014).Dyspepsia and gastro-oesophageal reflux disease - Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both
  2. Yeomans ND.Gastritis. Medicine International 1994; 22(6):221-4.
  3. Bayerdorffer E et al. Lancet 1995;345: 1591-3.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.